Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 3Withdrawn 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 2Recurrence 1Prostatic Neoplasms 1Philadelphia Chromosome 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Hematologic Neoplasms 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 4Methotrexate 4Cyclosporine 4Tacrolimus 3Radiotherapy 3Mycophenolic Acid 3Cyclophosphamide 3Whole-Body Irradiation 2Pentetic Acid 2Busulfan 2ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Transplantation 1Therapeutics 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentostatin 1Minocycline 1Methylprednisolone 1Melphalan 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Idarubicin 1Heparin 1Flow Cytometry 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Accelerated Phase × Dasatinib × Clear all
NCT03414450 2018-10-25

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

EDDC (Experimental Drug Development Centre), A*STAR Research Entities

Phase 1 Withdrawn
Other hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡